Oxford Biomedica plc (LON: OXB)

Oxford Biomedica Balance Sheet

Financials in millions GBP. Fiscal year is January - December.

Fiscal Year	TTM	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Jun 30, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Cash & Equivalents	81.41	103.72	141.29	108.94	46.74	16.24
Trading Asset Securities	-	-	-	0.07	0.24	2.72
Cash & Short-Term Investments	81.41	103.72	141.29	109.02	46.98	18.96
Cash Growth	-37.10%	-26.59%	29.60%	132.04%	147.77%	-41.19%
Accounts Receivable	25.66	13.34	45.01	35.95	47.33	26.17
Other Receivables	10.83	7.04	12.61	6.15	4.1	7.45
Receivables	36.49	20.39	57.62	42.1	51.42	33.62
Inventory	16.57	12.87	12.63	9.52	6.91	2.58
Prepaid Expenses	4.34	4.36	3.98	3.21	2.63	1.77
Total Current Assets	138.88	141.33	215.5	163.84	107.95	56.94
Property, Plant & Equipment	71.6	75.69	133.78	69.73	72.3	61.93
Goodwill	-	-	0.66	-	-	-
Other Intangible Assets	29.99	30.98	105.23	0.05	0.07	0.1
Long-Term Deferred Tax Assets	-	-	-	-	-	0.36
Other Long-Term Assets	4.51	4.34	5.01	3.61	3.61	3.61
Total Assets	244.97	252.34	460.18	237.23	183.93	122.93
Accounts Payable	13.01	6.05	13.6	5.26	7.78	7.31
Accrued Expenses	11.95	10.27	20.63	11.9	10.35	5.94
Current Portion of Leases	4.26	3.65	3.3	0.85	4.48	0.48
Current Income Taxes Payable	1.97	1.48	2.35	1.9	1.59	1.04
Current Unearned Revenue	24.44	22.11	19.26	13.4	28.26	14.16
Other Current Liabilities	2.98	0.75	-	-	-	-
Total Current Liabilities	59.15	44.32	59.66	33.31	52.46	28.94
Long-Term Debt	39.18	38.53	39.78	-	-	-
Long-Term Leases	66.31	69.27	71.21	8.49	9.37	7.91
Long-Term Unearned Revenue	0.69	5.33	1.15	1.85	3.52	5.01
Long-Term Deferred Tax Liabilities	-	-	5.59	-	-	0.36
Other Long-Term Liabilities	8.42	17.06	46.61	6.24	5.84	5.09
Total Liabilities	173.75	174.51	223.99	49.89	71.18	47.3
Common Stock	52.65	48.4	48.13	43.09	41.16	38.42
Additional Paid-In Capital	394.83	380.33	379.95	307.77	258.02	222.62
Retained Earnings	-390.06	-352.92	-198.55	-165.81	-188.72	-187.7
Comprehensive Income & Other	8.84	-1.81	-24.89	2.29	2.29	2.29
Total Common Equity	66.26	74.01	204.65	187.34	112.75	75.63
Minority Interest	4.96	3.83	31.54	-	-	-
Shareholders' Equity	71.22	77.83	236.19	187.34	112.75	75.63
Total Liabilities & Equity	244.97	252.34	460.18	237.23	183.93	122.93
Total Debt	110.31	111.46	114.28	9.34	13.85	8.39
Net Cash (Debt)	-28.9	-7.74	27	99.68	33.14	10.57
Net Cash Growth	-	-	-72.91%	200.80%	213.41%	-
Net Cash Per Share	-0.29	-0.08	0.28	1.16	0.41	0.15
Filing Date Shares Outstanding	105.3	96.8	96.26	86.18	82.32	76.86
Total Common Shares Outstanding	105.3	96.8	96.26	86.18	82.32	76.86
Working Capital	79.73	97.01	155.84	130.54	55.49	28
Book Value Per Share	0.63	0.76	2.13	2.17	1.37	0.98
Tangible Book Value	36.27	43.03	98.77	187.29	112.67	75.54
Tangible Book Value Per Share	0.34	0.44	1.03	2.17	1.37	0.98
Machinery	70.58	65.33	61.02	40.17	33.71	27.57
Leasehold Improvements	61.09	61.06	60.23	28.15	27.22	21.91
Order Backlog	-	104	94	-	-	-

Source: S&P Capital IQ. Standard template. Financial Sources.